New Approaches to Postpartum Depression
neuroscienceCME WebcastPremiere Date: Monday, February 12, 2018
This activity offers CE credit for:%>
- Physicians (CME)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, February 12, 2019
Note: Credit Is No Longer Available
|Anita H. Clayton, MD
Chair of Psychiatry and Neurobehavioral Sciences
David C. Wilson Professor of Psychiatry
University of Virginia School of Medicine
This video is a replay of a plenary session from the 10th Annual Chair Summit Master Class for Neuroscience Professional Development held in New Orleans, LA on November 16-18, 2017.
At the end of this CE activity, participants should be able to:
- Increase screening by 50% for postpartum depression (PPD) in at-risk patients.
- Examine current strategies to improve clinical outcomes in PPD.
- Evaluate the benefits and the risks of emerging therapies in improving treatment response and remission in PPD.
This activity is supported by an educational grant from Sage Therapeutics, Inc.
Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other nonphysical healthcare professionals with an interest in psychiatry, neurology, and the neurosciences.
CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, sue of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentation.
Dr. Clayton reports that she receives grant funding as the principal investigator on research grants at UVA from Allergan; Axsome Therapeutics, Inc.; Janssen Pharmaceuticals, Inc.; Palatin Technologies, Inc.; SAGE Therapeutics; and Takeda Pharmaceuticals U.S.A., Inc. She is a consultant for Fabre-Kramer Pharmaceuticals, Inc.; Palatin Technologies, Inc.; $1 Biopharma, Inc.; Sprout Pharmaceuticals, Inc. (a division of Valiant Pharmaceuticals); and received a fee to UVA from Takeda Pharmaceuticals U.S.A. Inc. She is a restricted stock holder with Euthymics Bioscience; $1 Biopharma, Inc. She receives royalties from Balantine Books; Guildford Pub; and CSFQ (Changes in Sexual Functioning Questionnaire).
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
Daniela V. DiBiase, MS (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff. No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).